Linked Life Data

14965804

Source:http://linkedlifedata.com/resource/pubmed/id/14965804

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-2-17
pubmed:abstractText
Eczema molluscatum describes the occurrence of molluscum contagiosum virus infection in a patient with underlying atopic dermatitis. Novel, safe and effective treatment options in atopic dermatitis are the topical immunomodulators tacrolimus and pimecrolimus. One major advantage over corticosteroids is that they do not induce skin atrophy. Some physicians fear that topical immunomodulators may predispose patients to skin infections. We observed a patient with atopic dermatitis who developed eczema molluscatum during treatment with tacrolimus 0.1% ointment. After withdrawal of tacrolimus, the lesions resolved spontaneously over 3 weeks.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1167-1122
pubmed:author
pubmed:copyrightInfo
Copyright John Libbey Eurotext 2003.
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
73-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Eczema molluscatum in tacrolimus treated atopic dermatitis.
pubmed:affiliation
Department of Dermatology, Ludwig-Maximilians-University, Frauenlobstrasse 9-11, 80337 München, Germany.
pubmed:publicationType
Journal Article, Case Reports